See more : JOOYONTECH CO., Ltd (044380.KS) Income Statement Analysis – Financial Results
Complete financial analysis of Invacare Corporation (IVC) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Invacare Corporation, a leading company in the Medical – Instruments & Supplies industry within the Healthcare sector.
You may be interested
- Universal Copper Ltd. (ECMXF) Income Statement Analysis – Financial Results
- PT Indo Straits Tbk (PTIS.JK) Income Statement Analysis – Financial Results
- Kootenay Silver Inc. (KOOYF) Income Statement Analysis – Financial Results
- Al-Dawaa Medical Services Company (4163.SR) Income Statement Analysis – Financial Results
- Electric Royalties Ltd. (ELECF) Income Statement Analysis – Financial Results
Invacare Corporation (IVC)
About Invacare Corporation
Invacare Corporation, together with its subsidiaries, designs, manufactures, distributes, and exports medical equipment for use in home health care, retail, and extended care markets worldwide. The company offers mobility and seating products, such as power wheelchairs under the Invacare TDX brand; custom manual wheelchairs under the Invacare, Invacare Top End, and Küschall brand names; and seating and positioning products under the Invacare brand, as well as custom molded seat modules under the PinDot brand. It also provides lifestyle products, including pressure relieving overlays and mattress systems under the Invacare Softform and microAIR brands; safe patient handling products under the Birdie, Evo, and ISA brands; residential and institutional care beds and bed accessories, and manual wheelchairs under the Invacare brand name; and personal care products. In addition, the company offers respiratory therapy products comprising stationary oxygen concentrators under the Platinum and Perfecto2 brands; portable oxygen concentrators under the Platinum brand; and Invacare HomeFill oxygen systems. Further, it provides repair, equipment rentals, and external contracting services, as well as distributes heart rate monitors, thermometers, and nebulizers; and portable ramps. The company sells its products primarily to home medical equipment providers through retail and e-commerce channels, as well as to residential care operators, dealers, and government health service customers through its sales force, independent manufacturers' representatives, and distributors. Invacare Corporation was founded in 1885 and is headquartered in Elyria, Ohio.
| Metric | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 | 1996 | 1995 | 1994 | 1993 | 1992 | 1991 | 1990 | 1989 | 1988 | 1987 | 1986 | 1985 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 741.73M | 872.46M | 850.69M | 927.96M | 972.35M | 966.50M | 1.05B | 1.14B | 1.27B | 1.35B | 1.46B | 1.80B | 1.72B | 1.69B | 1.76B | 1.60B | 1.50B | 1.53B | 1.40B | 1.25B | 1.09B | 1.05B | 1.01B | 878.30M | 797.50M | 653.40M | 619.50M | 504.00M | 411.10M | 365.50M | 305.20M | 263.20M | 229.80M | 186.10M | 160.80M | 130.80M | 111.50M | 94.30M |
| Cost of Revenue | 566.34M | 633.35M | 605.44M | 665.90M | 704.67M | 697.25M | 763.85M | 829.51M | 922.78M | 974.89M | 1.01B | 1.28B | 1.21B | 1.20B | 1.27B | 1.16B | 1.08B | 1.08B | 984.74M | 872.52M | 761.76M | 735.29M | 673.32M | 581.10M | 535.20M | 436.70M | 400.10M | 323.60M | 265.30M | 238.80M | 197.80M | 170.50M | 153.10M | 129.20M | 108.70M | 88.40M | 74.90M | 66.30M |
| Gross Profit | 175.39M | 239.11M | 245.25M | 262.07M | 267.68M | 269.25M | 283.63M | 312.82M | 347.39M | 377.47M | 444.90M | 518.48M | 509.64M | 493.19M | 488.89M | 446.30M | 417.07M | 448.51M | 418.59M | 374.66M | 327.40M | 318.35M | 339.84M | 297.20M | 262.30M | 216.70M | 219.40M | 180.40M | 145.80M | 126.70M | 107.40M | 92.70M | 76.70M | 56.90M | 52.10M | 42.40M | 36.60M | 28.00M |
| Gross Profit Ratio | 23.65% | 27.41% | 28.83% | 28.24% | 27.53% | 27.86% | 27.08% | 27.38% | 27.35% | 27.91% | 30.57% | 28.79% | 29.59% | 29.13% | 27.85% | 27.86% | 27.84% | 29.32% | 29.83% | 30.04% | 30.06% | 30.21% | 33.54% | 33.84% | 32.89% | 33.16% | 35.42% | 35.79% | 35.47% | 34.66% | 35.19% | 35.22% | 33.38% | 30.57% | 32.40% | 32.42% | 32.83% | 29.69% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 0.00 | 0.00 | 0.00 | 260.06M | 281.91M | 296.82M | 303.78M | 319.85M | 383.91M | 401.82M | 414.50M | 422.10M | 411.51M | 0.00 | 398.25M | 366.85M | 373.85M | 341.78M | 297.12M | 262.02M | 220.30M | 195.57M | 201.54M | 177.60M | 157.60M | 160.10M | 136.10M | 112.20M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 226.78M | 232.24M | 236.36M | 260.06M | 281.91M | 296.82M | 303.78M | 319.85M | 383.91M | 401.82M | 414.50M | 422.10M | 411.51M | 398.65M | 398.25M | 366.85M | 373.85M | 341.78M | 297.12M | 262.02M | 220.30M | 195.57M | 201.54M | 177.60M | 157.60M | 160.10M | 136.10M | 112.20M | 89.30M | 77.50M | 69.80M | 60.90M | 53.30M | 43.10M | 38.10M | 33.30M | 29.20M | 26.30M |
| Other Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 24.20M | 40.16M | 2.88M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 8.97M | 31.47M | 26.00M | 23.80M | 18.30M | 17.90M | 14.20M | 12.70M | 12.30M | 10.00M | 8.10M | 6.60M | 5.00M | 3.20M | 2.70M | 2.20M | -55.60M |
| Operating Expenses | 226.78M | 232.24M | 236.36M | 260.06M | 281.91M | 296.82M | 303.78M | 319.85M | 383.91M | 401.82M | 414.50M | 446.30M | 451.68M | 401.52M | 398.25M | 366.85M | 373.85M | 341.78M | 297.12M | 262.02M | 220.30M | 204.55M | 233.01M | 203.60M | 181.40M | 178.40M | 154.00M | 126.40M | 102.00M | 89.80M | 79.80M | 69.00M | 59.90M | 48.10M | 41.30M | 36.00M | 31.40M | -29.30M |
| Cost & Expenses | 793.12M | 865.59M | 841.79M | 925.96M | 986.58M | 994.06M | 1.07B | 1.15B | 1.31B | 1.38B | 1.43B | 1.73B | 1.66B | 1.60B | 1.67B | 1.52B | 1.45B | 1.42B | 1.28B | 1.13B | 982.06M | 939.84M | 906.33M | 784.70M | 716.60M | 615.10M | 554.10M | 450.00M | 367.30M | 328.60M | 277.60M | 239.50M | 213.00M | 177.30M | 150.00M | 124.40M | 106.30M | 94.30M |
| Interest Income | -56.00K | -1.00K | 93.00K | 429.00K | 534.00K | 473.00K | 265.00K | 165.00K | 507.00K | 384.00K | 685.00K | 1.44M | 724.00K | 1.67M | 0.00 | 0.00 | -2.78M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Expense | 28.52M | 24.31M | 28.50M | 29.08M | 28.34M | 22.91M | 15.88M | 2.91M | 3.04M | 3.51M | 9.12M | 7.96M | 20.65M | 33.15M | 39.23M | 44.31M | 3.75M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation & Amortization | -10.99M | 16.82M | 21.27M | 24.49M | 15.56M | 14.63M | 14.64M | 19.43M | 32.79M | 36.79M | 38.59M | 38.88M | 36.80M | 40.56M | 43.74M | 43.72M | 37.71M | 40.52M | 32.32M | 27.24M | 26.64M | 33.45M | 31.47M | 26.00M | 23.80M | 18.30M | 17.90M | 14.20M | 12.70M | 12.30M | 10.00M | 8.10M | 6.60M | 5.00M | 3.20M | 2.70M | 2.20M | 1.70M |
| EBITDA | -80.47M | 2.01M | 25.33M | 2.01M | -14.23M | -28.71M | -42.86M | 10.86M | -14.69M | 86.01M | 67.78M | 52.43M | 95.49M | 120.99M | 95.25M | 79.46M | 43.22M | 111.83M | 142.69M | 133.64M | 123.17M | 99.84M | 129.69M | 94.00M | 98.90M | 23.60M | 81.70M | 66.10M | 54.60M | 45.80M | 37.50M | 31.00M | 20.50M | 10.00M | 11.60M | 7.50M | 7.50M | 400.00K |
| EBITDA Ratio | -10.85% | 0.23% | 2.98% | 1.03% | 1.01% | -2.97% | 0.09% | 0.95% | -1.16% | 6.36% | 4.66% | 2.91% | 5.55% | 7.15% | 5.42% | 3.63% | -18.14% | 7.31% | 10.17% | 10.72% | 11.31% | 9.48% | 12.80% | 10.70% | 12.40% | 3.61% | 13.19% | 13.12% | 13.28% | 12.53% | 12.29% | 11.78% | 8.92% | 5.37% | 7.21% | 5.73% | 6.73% | 0.42% |
| Operating Income | -69.48M | -14.81M | 11.33M | -10.41M | -18.29M | -40.16M | -15.22M | -7.02M | -36.53M | -24.36M | 30.40M | 12.11M | 57.96M | 78.76M | 90.64M | 79.46M | 43.22M | 99.43M | 121.47M | 112.65M | 107.10M | 113.80M | 106.83M | 93.60M | 80.90M | 38.30M | 65.40M | 54.00M | 43.80M | 36.90M | 27.60M | 23.70M | 16.80M | 8.80M | 10.80M | 6.40M | 5.20M | -1.30M |
| Operating Income Ratio | -9.37% | -1.70% | 1.33% | -1.12% | -1.88% | -4.16% | -1.45% | -0.61% | -2.88% | -1.80% | 2.09% | 0.67% | 3.37% | 4.65% | 5.16% | 4.96% | 2.89% | 6.50% | 8.66% | 9.03% | 9.83% | 10.80% | 10.54% | 10.66% | 10.14% | 5.86% | 10.56% | 10.71% | 10.65% | 10.10% | 9.04% | 9.00% | 7.31% | 4.73% | 6.72% | 4.89% | 4.66% | -1.38% |
| Total Other Income/Expenses | -17.54M | -14.88M | -35.77M | -46.03M | -19.87M | 10.29M | 13.30M | -4.72M | -26.69M | -13.98M | -20.43M | -90.79M | -19.92M | -47.27M | -39.14M | -64.97M | -352.75M | -28.13M | -11.10M | -6.24M | -10.57M | -47.41M | -8.62M | -25.60M | -5.80M | -33.00M | -1.60M | -2.10M | -1.90M | -3.40M | -100.00K | -800.00K | -2.90M | -3.80M | -2.40M | -1.60M | 100.00K | 0.00 |
| Income Before Tax | -98.00M | -39.12M | -24.44M | -44.03M | -34.10M | -66.25M | -29.56M | -11.74M | -63.21M | -38.34M | 9.97M | 5.59M | 38.04M | 47.28M | 51.50M | 14.49M | -309.52M | 71.30M | 110.37M | 106.41M | 96.53M | 66.39M | 98.22M | 68.00M | 75.10M | 5.30M | 63.80M | 51.90M | 41.90M | 33.50M | 27.50M | 22.90M | 13.90M | 5.00M | 8.40M | 4.80M | 5.30M | -1.30M |
| Income Before Tax Ratio | -13.21% | -4.48% | -2.87% | -4.74% | -3.51% | -6.85% | -2.82% | -1.03% | -4.98% | -2.84% | 0.69% | 0.31% | 2.21% | 2.79% | 2.93% | 0.90% | -20.66% | 4.66% | 7.87% | 8.53% | 8.86% | 6.30% | 9.69% | 7.74% | 9.42% | 0.81% | 10.30% | 10.30% | 10.19% | 9.17% | 9.01% | 8.70% | 6.05% | 2.69% | 5.22% | 3.67% | 4.75% | -1.38% |
| Income Tax Expense | 3.07M | 6.45M | 3.84M | 9.30M | 9.82M | 10.29M | 13.30M | 14.71M | 5.55M | 12.66M | 18.24M | 9.70M | 12.70M | 6.10M | 12.95M | 13.30M | 8.25M | 22.45M | 35.18M | 35.00M | 31.76M | 31.20M | 38.31M | 26.50M | 29.30M | 3.70M | 24.90M | 19.70M | 15.50M | 11.40M | 9.80M | 8.80M | 6.30M | 2.40M | 3.30M | 2.40M | 1.90M | -200.00K |
| Net Income | -101.07M | -45.56M | -28.28M | -53.33M | -43.92M | -76.54M | -42.86M | -26.19M | -56.07M | 33.05M | 1.83M | -4.11M | 25.34M | 41.18M | 38.55M | 1.19M | -317.77M | 48.85M | 75.20M | 71.41M | 64.77M | 35.19M | 59.91M | 41.50M | 45.80M | 1.60M | 38.90M | 32.20M | 26.40M | 22.10M | 17.70M | 14.10M | 7.60M | 2.60M | 5.10M | 2.40M | 3.40M | -1.10M |
| Net Income Ratio | -13.63% | -5.22% | -3.32% | -5.75% | -4.52% | -7.92% | -4.09% | -2.29% | -4.41% | 2.44% | 0.13% | -0.23% | 1.47% | 2.43% | 2.20% | 0.07% | -21.21% | 3.19% | 5.36% | 5.73% | 5.95% | 3.34% | 5.91% | 4.73% | 5.74% | 0.24% | 6.28% | 6.39% | 6.42% | 6.05% | 5.80% | 5.36% | 3.31% | 1.40% | 3.17% | 1.83% | 3.05% | -1.17% |
| EPS | -2.77 | -1.29 | -0.82 | -1.59 | -1.31 | -2.34 | -1.32 | -0.81 | -1.75 | 1.04 | 0.06 | -0.13 | 0.78 | 1.29 | 1.21 | 0.04 | -10.00 | 1.55 | 2.41 | 2.31 | 2.10 | 1.15 | 1.99 | 1.38 | 1.53 | 0.05 | 1.28 | 1.07 | 0.89 | 0.77 | 0.62 | 0.52 | 0.33 | 0.12 | 0.23 | 0.11 | 0.15 | -0.05 |
| EPS Diluted | -2.77 | -1.29 | -0.82 | -1.59 | -1.31 | -2.30 | -1.32 | -0.80 | -1.74 | 1.03 | 0.06 | -0.13 | 0.78 | 1.29 | 1.21 | 0.04 | -10.00 | 1.51 | 2.32 | 2.25 | 2.05 | 1.11 | 1.95 | 1.36 | 1.50 | 0.05 | 1.28 | 1.07 | 0.89 | 0.77 | 0.62 | 0.52 | 0.33 | 0.12 | 0.23 | 0.11 | 0.15 | -0.05 |
| Weighted Avg Shares Out | 36.52M | 35.27M | 34.38M | 33.64M | 33.54M | 32.75M | 32.47M | 32.17M | 32.01M | 31.92M | 31.64M | 31.96M | 32.39M | 31.97M | 31.90M | 31.84M | 31.79M | 31.56M | 31.15M | 30.86M | 30.87M | 30.62M | 30.13M | 30.14M | 29.93M | 29.57M | 30.39M | 30.08M | 29.66M | 28.81M | 28.71M | 27.33M | 23.11M | 22.55M | 22.28M | 22.28M | 22.28M | 22.22M |
| Weighted Avg Shares Out (Dil) | 36.52M | 35.27M | 34.38M | 33.64M | 33.54M | 33.22M | 32.59M | 32.68M | 32.20M | 32.04M | 31.87M | 31.96M | 32.69M | 32.00M | 31.95M | 31.93M | 31.79M | 32.45M | 32.35M | 31.73M | 31.66M | 31.68M | 30.76M | 30.62M | 30.58M | 30.37M | 30.39M | 30.08M | 29.66M | 28.81M | 28.71M | 27.33M | 23.11M | 22.55M | 22.28M | 22.28M | 22.28M | 22.22M |
Invacare Corporation: Milberg Coleman Bryson Phillips Grossman PLLC Announces Investigation of Invacare Corporation
NEW YORK, Jan. 31, 2022 /PRNewswire/ -- Milberg Coleman Bryson Phillips Grossman PLLC ("Milberg") is currently investigating Invacare Corporation (Invacare) (NYSE: IVC) in connection with the issuance of a warning letter to Invacare by the United States Food & Drug Administration...
Invacare Announces New Features in LiNX® 3 Electronics
ELYRIA, Ohio--(BUSINESS WIRE)--Invacare Corporation (NYSE: IVC) is pleased to announce exciting new features available in LiNX® electronics which incorporates Invacare's well known MK6™ features. The LiNX system facilitates the control of a power wheelchair, making it easy for end users...
3 Hot Penny Stocks to Watch As The First Week of January Ends
Here are three penny stocks to watch as the first week of January ends The post 3 Hot Penny Stocks to Watch As The First Week of January Ends appeared first on Penny Stocks to Buy, Picks, News and Information...
Best Penny Stocks To Buy Now? 10 Short Squeeze Stocks To Watch
Looking for potential short squeeze penny stocks? Start by looking at short interest The post Best Penny Stocks To Buy Now?
Invacare To Realign Its Europe, Asia Pacific Businesses
Invacare Corporation (NYSE: IVC) will be realigning its Europe and the Asia Pacific businesses under a single leader to streamline operations. To lead this strategic business realignment, Geoff Purtill has been appointed Senior Vice President and General Manager, EMEA, and the Asia Pacific.
Invacare Corporation Announces Strategic Realignment of EMEA & APAC Businesses
ELYRIA, Ohio--(BUSINESS WIRE)--Invacare Corporation (NYSE:IVC)(“Invacare” or the “company”) today announced that it will be realigning its Europe and Asia Pacific businesses under a single leader to streamline operations and enhance the customer experience. To lead this strategic business realignment, Geoff...
5 Penny Stocks To Watch Right Now With High Short Interest
Will these penny stocks see a squeeze? The post 5 Penny Stocks To Watch Right Now With High Short Interest appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.
5 Short Squeeze Penny Stocks To Buy For Under $5 Right Now
5 short squeeze penny stocks to buy for under $5. Are they worth the risk?
The Top 3 Penny Stocks to Buy Heading Into the Year-End
Penny stocks are criticized for being too risky, but a little bit of diversification will not hurt your portfolio, especially with these names. The post The Top 3 Penny Stocks to Buy Heading Into the Year-End appeared first on InvestorPlace.
Kyndryl Holdings Set to Join S&P MidCap 400; NetScout Systems to Join S&P SmallCap 600
NEW YORK, Nov. 1, 2021 /PRNewswire/ -- Kyndryl Holdings Inc. (NYSE:KD) will replace NetScout Systems Inc. (NASD:NTCT) in the S&P MidCap 400, and NetScout Systems will replace Invacare Corp. (NYSE:IVC) in the S&P SmallCap 600 effective prior to the opening of...
Source: https://incomestatements.info
Category: Stock Reports